| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.26 | 6e-07 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-07 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-06 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.17 | 6e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-06 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |